19.88000 EUR
0
0%
Last update Sep 24, 9:05 AM CEST
Main market
Day range
19.88000
19.88000
Previous close
19.88000
Open
19.88000
Access this stock data via API
Subscribe
Acadia Pharmaceuticals Inc.
19.88
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 816.3M 699.2M 517.2M 484.1M
Cost of revenue 69.7M 40.1M 10.2M 19.1M
Gross profit 746.5M 659.1M 507.1M 465.0M
Operating expense
Research & development 258.4M 338.4M 361.6M 239.4M
Selling general and admin 416.3M 391.3M 369.1M 396.0M
Other operating expenses
Operating income 71.8M -70.6M -223.6M -170.4M
Non operating interest income
Income 21.7M 16.6M 6.6M 591K
Expense
Other income expense 126.4M 4.9M 3.5M 2.3M
Pretax income 219.9M -49.1M -213.4M -167.5M
Tax provision 27.0M 9.9M 2.5M 351K
Net income 193.0M -59.0M -216.0M -167.9M
Basic EPS 1.4 -0.4 -1.3 -1.1
Diluted EPS 1.4 -0.4 -1.3 -1.1
Basic average shares 141.2M 163.8M 166.0M 164.8M
Diluted average shares 141.2M 163.8M 166.0M 164.8M
EBITDA -39.5M -65.3M -221.6M -167.1M
Net income from continuing op. 193.0M -59.0M -216.0M -167.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 48 minutes

13:11
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).